Anne Maryjo (Griffin) Neilan MD
Infectious Disease
Research Fellow in Medicine, Massachusetts General Hospital
Join to View Full Profile
Massachusetts General Hospital55 Fruit StreetBoston, MA 02114
Phone+1 617-726-7782
Fax+1 617-726-7653
Dr. Neilan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2011 - 2013- Mass General Brigham/Massachusetts General Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 2007 - 2011
Icahn School of Medicine at Mount SinaiClass of 2007
Certifications & Licensure
MA State Medical License 2009 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2016-2017
Publications & Presentations
PubMed
- Long-Acting PrEP for People With High Vulnerability to HIV Acquisition in Brazil: A Cost-Effectiveness Analysis.Wanyi Chen, Paula M Luz, Anjali Srinivasan, Beatriz Grinsztejn, Justine A Scott
Journal of the International AIDS Society. 2026-05-01 - Potential long-acting tuberculosis treatment for people with HIV: cost-effectiveness benchmarks.Amy Zheng, Eden Pletner, Keren Middelkoop, Anne M Neilan, C Robert Horsburgh
Annals of the American Thoracic Society. 2026-05-01 - Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness.Sujata E Tewari, Risa Hoffman, Shahin Lockman, Clare F Flanagan, Karen A Webb
The Journal of Infectious Diseases. 2026-01-17
Press Mentions
Court Ruling on PrEP Could Lead to More Than 2,000 HIV Infections in the Next YearMarch 23rd, 2023- To Be Cost Effective, Injectable PrEP Can Only Cost About $3000 More Than US Generic Oral PrEPMarch 15th, 2021
- Low-Cost, Frequent COVID-19 Screening of Asymptomatic People Could Decrease Infections, Deaths and Be Cost-EffectiveSeptember 23rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
